|
 |
|
|
|
|
- Huzly, D. & Hess, R.D, 2007. Möglichkeiten und Grenzen der serologischen Epstein-Barr-Virus-Diagnostik. Deutsche Medizinische Wochenschrift 132: 151-154.
|
|
|
________________________________________________________________________________________
|
|
|
- Hess, R.D. Das H5N1-Influenza.A-Virus (1), 2006. Eine Bedrohung für den Menschen? MTA Dialog 4: 258-260.
|
|
|
________________________________________________________________________________________
|
|
|
- Hess, R.D. Das H5N1-Influenza.A-Virus (2), 2006. Eine Bedrohung für den Menschen? MTA Dialog 5: 378-381.
|
|
|
________________________________________________________________________________________
|
|
|
- Hess, R.D., Gaertner B.C., Garrett, P. (2005)Meeting Report on Molecular Virology Workshop (April 23-24,2004) and the 20th Annual Clinical Virology Symposium, Clearwater, FL, USA (April 25-28, 2004) J Clin Virol, 32: 259-262, 2005.
|
|
|
________________________________________________________________________________________
|
|
|
Hess, R.D., Gaertner B.C., Garrett, P. (2005) Meeting Report. Part II: Notes from the Twentieth Annual Clinical Virology Symposium. J Clin Virol, 32: 342-346, 2005
|
|
|
________________________________________________________________________________________
|
|
|
Hess, R.D., Gaertner B.C., Garrett, P. (2005) Meeting Report, Part III: Notes from the Twentieth Annual Clinical Virology Symposium, April 25-28, 2004, Clearwater Beach, Florida, USA J Clin Virol, 33: 83-87, 2005
|
|
|
________________________________________________________________________________________
|
|
|
Csango, P.A., Pedersen, J.E., Hess, R.D. (2004). Comparison of four Mycoplasma pneumoniae IgM-, IgG-, and IgA-specific commercially available enzyme immunoassays in healthy blood donors and patients with other diseases. Clinical Microbiology and Infection 10: 1094-1098.
|
|
|
|
|
|
|
________________________________________________________________________________________
|
|
|
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Gärtner, B.C., Hess, R.D., Bandt, D., Kruse, A., Rethwilm, A., Roemer, K., Mueller-Lantzsch, N. (2003). Evaluation of four commercially available Epstein-Barr Virus Enzyme Immunoassays with an immunofluorescence as the reference method. Clin Diag Lab Immunol 10: 78-82.
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Hess, RD, (2002). Aktuelle virale Darminfektionen: Erreger, Klinik und Diagnostik oder das kleine 1x1 der viralen Gastroenteritis. Teil 1: Erreger und Systematik, MTA Dialog 9 (3): 750-754.
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Hess, RD, (2002). Aktuelle virale Darminfektionen: Erreger, Klinik und Diagnostik oder das kleine 1x1 der viralen Gastroenteritis.Teil 2: Klinik und Diagnostik, MTA Dialog 11 (3): 964-970.
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Metzger, C., Terletskaia-Ladwig, C., Hess, R.D., Enders, G. (2001). Rationale und rationelle Enterovirus-Diagnostik. Dt. Med. Wochenschrift (DMW) 126: 289-293
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Hess, R.D., Lieske, R., Klopfer, G., Acheson, D.W.K. (1999). Conclusions from a questionnaire on STEC/VTEC diagnostics in the Federal Republic of Germany. J Lab Med 23: 427-436.
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Hess, R.D., Lieske, R., Klopfer, G., Acheson, D.W.K. (1999). Conclusions from a questionnaire on STEC/VTEC diagnostics in the federal republic of Germany. Poster presentation ASM, Chicago, Il, USA, June 1st, 1999
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Hess, RD, Lieske, R, Weber, B. 1999. The 2nd International Symposium of the European Study Group on Enterohemorrhagic Escherichia coli (EHEC). Emerging Infectious Diseases 5: 730-733
|
|
|
|
|
________________________________________________________________________________________
|
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Obert, M., Pleuger, H., Hanagarth, H., Schulte-Mönting, J., Wiesmüller, K.H., Braun, D.G., Brandner, G., Hess, R.D. (1998). Protection of mice against SV40 tumours by Pam3Cys, MTP-PE and Pam3Cys conjugated with the SV40 T antigen-derived peptide K(698)-T(708). Vaccine, 16: 161-169.
|
|
|
________________________________________________________________________________________
|
|
|
Brandstetter, T., Ninci, E., Falken, U., Wagner, E., Hess, R., Bauknecht, T. (1998). RHG-CSF affects genes involved in mitogen signalling and early gene expression in the ovarian cancer cell line HEY. Int J Cancer 75: 847-854.
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Ihling, C., Haendeler, J., Hess, R.D., Schaefer, H.E., Zeiher, A.M. (1998). Coexpression of p53 and MDM2 in human atherosclerosis: implications forthe regulation of cellularty of artherosclerotic lesions. J Pathol, 185: 303-312.
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Siegel, J., Brandner, G, Hess, R.D. (1998). Cross-reactivity of the monoclonal antibody 9E10 with murine c-MYC. Int J Oncol, 13: 1259-1262.
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Merlin, T., Brandner, G., Hess, R.D. (1998). Cell cycle arrest in ovarian cancer cell lines does not depend on p53 status upon treatment with cytostatic drugs. Int J Oncol, 13: 1007-1016.
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Merlin, T., Hess, R.D., Einzmann, T., Bauknecht, T., Brandner G.. (1997) p53-dependent and independent apoptosis, and cell cycle arrest in ovarian cancer cell lines after treatment with cisplatin, etoposide, gemcitabine and paclitaxel. J Cancer Res Clin Oncol, 123: 33.
|
|
|
________________________________________________________________________________________
|
|
|
Hess, R.D., Brandner, G. (1997). DNA-damage-inducible p53 activity in SV40-transformed cells. Oncogene 15: 2501-2401.
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Ihling, C., Menzel, G., Hess, R.D., Fraedrich, G., Schaefer, H.E., Zeiher, M. (1996). Evidence for MDM2/p53 complex formation in advanced human atheroscleosis: implications for the regulation of atherosclerotic lesion cellularity. Circulation 94 (8), 3425 (Suppl.).
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Ihling, C., Menzel, G., Hess, R., Welles, E., Schaefer, H.E., Zeiher, A.M. (1996). Topographical association between the cyclin-dependent kinase inhibitor p21 and cellular proliferation in human atherosclerotic tissue. Circulation 94 (8), 3734 (Suppl.).
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Ihling, C., Menzel, G., Hess, R., Hoh, M., Fraedrich, G., Schaefer, H.E., Zeiher, A.M. (1996). P53-Akkumulation, MDM2-Expression und Apoptose bei humaner Atherosklerose. Verh. Dtsch. Ges. Path: 80, 672.
|
|
|
________________________________________________________________________________________
|
|
|
Hess, R.D. and Brandner, G. (1996). DNA damage by filtered, tar- and aerosol-free cigarette smoke in rodent cells: a novel evaluation. Toxicol Lett, 88: 9-13.
|
|
|
________________________________________________________________________________________
|
|
|
Plaumann, B., Fritsche, M., Rimpler, H., Brandner, G, and Hess, R.D. (1996).Flavonoids activate wild-type p53. Oncogene, 13: 1605-1614.
|
|
|
________________________________________________________________________________________
|
|
|
Hess, R.D. & Brandner, G. (1996).p53 in normal and neoplastic tissue: analysis and function. (invited review) El J Pathol Histol, 961-07.
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Schmidt, R.J., Siegel, J., Haessler, C., Brandner, G. and Hess, R.D. (1995). P53 accumulation elicited by lipopolysaccharide (LPS) combined with interferon- and by NO-generating agents. J Cancer Res Clin Oncol 121, 12.
|
|
|
________________________________________________________________________________________
|
|
|
Schulze-Lutum, A., Siegel, J., Schmidt, R.J., Plaumann, B., Braun, C., Haessler, G. and Hess, R.D. (1995). Filtered, Tar-and aerosol-free cigarette smoke elicits accumulation of p53 in rodent cells. J Cancer Res Clin Oncol 121, 28.
|
|
|
________________________________________________________________________________________
|
|
|
Siegel, J., Hess, R.D., Plaumann, B., Haessler, C. and Brandner, G. (1995). Uptake of single-or double-stranded DNA sensitizes cells for the accumulation of p53 in response to DNA damage induced by mitomycin C. J Cancer Res Clin Oncol 121, 69.
|
|
|
________________________________________________________________________________________
|
|
|
Brandner, G., Schulze-Lutum, A., Hess, R. (1995). Genotoxicity of filtered, tar- and aerosol-free tobacco smoke in rodent cells. ZBL. Hyg. 198: 4.
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Agostini HJ, Gerstenecker B, Haessler C, Braun DG, Brandner G and Hess R.D. (1995). Monospecific polyclonal anti-anti-idiotypic antibodies to the carboxyterminal undecapeptide of the SV40 large tumor-antigen. Scand J Immunol, 41, 256-262.
|
|
|
________________________________________________________________________________________
|
|
|
Hess R.D. Kuther M, Haessler C, Paetzold, S., Braun DG, and Brandner G (1995). Quantitative cytofluorimetric determination of cell-membrane-associated large tumor antigen on SV40-transformed cells. Cytometry, 20, 81-85.
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Siegel, J., Fritsche, M., Mai, S., Brandner, G. and Hess, R.D. (1995). Enhanced p53 activity and accumulation in response to DNA damage upon DNA transfection. Oncogene 11: 1363-1370.
|
|
|
________________________________________________________________________________________
|
|
|
Fritsche M, Siegel J, Hess R, Plaumann B, Haessler C, Heinz B and Brandner G (1994).Nuclear accumulation of p53 in response to treatment with DNA-damaging agents: Detection of possible carcinogens.Zbl. Hyg. 195: 150.
|
|
|
________________________________________________________________________________________
|
|
|
Hanagarth HG, Obert M, Hess R, Haessler C, Braun DG, Brandner G (1994).Cell-binding carboxyterminal undecapeptide of SV40 tumor antigen provides immunity.Vaccine 12: 1197-1202.
|
|
|
________________________________________________________________________________________
|
|
|
Hess R, Oberbeck J, Grussenmeyer T, Schoeffel-Keller A, Haessler C, Braun DG and Brandner G (1994). PAb1614, a monoclonal antibody reactive with the tumor antigens of SV40, JC, BK, and polyoma virus and other JC virus tumor antigen crossreactive antibodies of the PAb1601-1636 panel. Intervirology 37:47-52.
|
|
|
________________________________________________________________________________________
|
|
|
Hess R, Rau P, Schwab M, Paetzold S, Kuther M, Obert M, Agostini H, Haessler C, Braun DG and Brandner G (1994). Covalent immunochemical membrane labelling of viable cells with K698-T708, a simian virus 40 tumor antigen-derived peptide. Peptide Research 7: 146-152.
|
|
|
________________________________________________________________________________________
|
|
|
Hess R, Plaumann B, Schulze Lutum A, Haessler C Heinz B, Fritsche M and Brandner G (1994). Nuclear accumulation of p53 in response to treatment with DNA damaging agents. Toxicol Lett 72: 43-52.
|
|
|
________________________________________________________________________________________
|
|
|
Schulze Lutum A, Siegel J, Plaumann B, Braun C, Haessler C, Brandner G and Hess RD (1994). Filtered, tar- and aerosol-free cigarette smoke causes accumulation of the tumor suppressor protein p53 in murine cells in vitro. Int J Oncol 5, 1405-1409.
|
|
|
________________________________________________________________________________________
|
|
|
Obert M, Hess R, Kuther M, Rau P, Haessler C, Braun DG and Brandner G (1993). Prevention of SV40 tumor growth by a bacterial lipopeptide derivative. J Cancer Res Clin Oncol 117:58.
|
|
|
|
|
________________________________________________________________________________________
|
|
|
Siegel J, Fritsche M, Hess R, Haessler C and Brandner G (1993).P53 accumulation assay: detection of possible carcinogens. J Cancer Res Clin Oncol 119: 85.
|
|
|
________________________________________________________________________________________
|
|
|
- Hess R, Hanagarth HG, Haessler C, Brandner G (1991).A peptide vaccine against simian virus 40 tumors. Cancer Res Clin Oncol 117: 11
|
|
|
|
